181 results on '"Cassinotti, Andrea"'
Search Results
2. Adalimumab for the treatment of Crohn's disease
3. Noninvasive Monitoring After Azathioprine Withdrawal in Patients With Inflammatory Bowel Disease in Deep Remission
4. Totally laparoscopic, multi-stage, restorative proctocolectomy for inflammatory bowel diseases. A prospective study on safety, efficacy and long-term results
5. Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD)
6. Virtual Chromoendoscopy With FICE for the Classification of Polypoid and Nonpolypoid Raised Lesions in Ulcerative Colitis
7. The PROSIT Cohort of Infliximab Biosimilar in IBD: A Prolonged Follow-up on the Effectiveness and Safety Across Italy
8. Endoscopic characterization of neoplastic and non-neoplastic lesions in inflammatory bowel disease: systematic review in the era of advanced endoscopic imaging.
9. Crohn’s Disease
10. Continuous clinical remission with biologics in ulcerative colitis: the ‘AURORA’ comparison study
11. Inter-observer agreement in endoscopic scoring systems: Preliminary report of an ongoing study from the Italian Group for Inflammatory Bowel Disease (IG-IBD)
12. ABO histo-blood group might modulate predisposition to Crohn's disease and affect disease behavior
13. Immunomodulatory effects of unselected haematopoietic stem cells autotransplantation in refractory Crohn's disease
14. Mucosal Healing Predicts Late Outcomes After the First Course of Corticosteroids for Newly Diagnosed Ulcerative Colitis
15. Evidence-based efficacy of methotrexate in adult Crohn’s disease in different intestinal and extraintestinal indications
16. Esophageal Stent in Sleeve Gastrectomy Leak Treatment: Observations Based on a Challenging Surgical Case and Literature
17. Anti-tumour necrosis factor α antibodies and circulating lymphocyte phenotypes in inflammatory bowel disease
18. IBD care in Europe: A comparative audit of the inpatient management of Crohn's disease and ulcerative colitis using the national UK IBD audit tool
19. Lower incidence of COVID‐19 in patients with inflammatory bowel disease treated with non‐gut selective biologic therapy
20. Use of double-balloon enteroscopy in the management of patients with Crohn’s disease: feasibility and diagnostic yield in a high-volume centre for inflammatory bowel disease
21. New onset of atrial fibrillation after introduction of azathioprine in ulcerative colitis: case report and review of the literature
22. CELL THERAPY IN INFLAMMATORY BOWEL DISEASE
23. Crohnʼs Disease Loci Are Common Targets of Protozoa-Driven Selection
24. Vitamin D and Inflammatory Bowel Disease
25. An Evolutionary Analysis of RAC2 Identifies Haplotypes Associated with Human Autoimmune Diseases
26. Modified Kudo classification can improve accuracy of virtual chromoendoscopy with FICE in endoscopic surveillance of ulcerative colitis
27. Maintenance Treatment With Azathioprine in Ulcerative Colitis: Outcome and Predictive Factors After Drug Withdrawal
28. CARD15 Gene Variants and Risk of Reoperation in Crohnʼs Disease Patients
29. HLA and Autoimmune Digestive Disease: A Clinically Oriented Review for Gastroenterologists
30. Prevalence and clinical significance of sonographic detection of enlarged regional lymph nodes in Crohnʼs disease
31. Use, effectiveness and tolerability of budesonide‐MMX in ulcerative colitis: A real‐life experience
32. Plasma miRNA‐based signatures in CRC screening programs
33. A Phase 2a, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial of IBD98-M Delayed-Release Capsules to Induce Remission in Patients with Active and Mild to Moderate Ulcerative Colitis
34. The PROSIT-BIO Cohort: A Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Infliximab Biosimilar
35. Certolizumab pegol: an evidence-based review of its place in the treatment of Crohn’s disease
36. Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD)
37. Adalimumab for the treatment of Crohn’s disease
38. Sa1221 Increasing Interobserver Agreement on IBD Endoscopic Scoring Systems: Results From the IGIBDEndo Educational Program
39. Immunity, autoimmunity and inflammatory bowel disease
40. Adalimumab for the treatment of Crohn’s disease
41. Certolizumab pegol: an evidence-based review of its place in the treatment of Crohn’s disease
42. Immunosuppressive and biologic therapy for ulcerative colitis
43. Su1917 Interobserver Agreement in IBD Endoscopic Scoring: Preliminary Results of an Ongoing IG-IBD Study
44. A Functional Variant in ERAP1 Predisposes to Multiple Sclerosis
45. Outcome of Cytomegalovirus (CMV) Colitis in Inflammatory Bowel Disease (IBD). A Retrospective Study
46. Is mucosal healing a predictor of decreased risk of Crohn's disease relapse after withdrawal of 1-year, successful adalimumab?
47. The Italian clinical experience with adalimumab in Crohn's disease: Eleven clinical cases
48. Review: Immunomodulators for all patients with inflammatory bowel disease?
49. Internet use among inflammatory bowel disease patients: an Italian multicenter survey
50. Incidence and clinical significance of immunogenicity to infliximab in Crohnʼs disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.